Our Full Hands-on Pomegranate Experience Heres what happened at every stage of ordering from Pomegranate, from the intake flow to the moment the vial reached our hands
The relationship between semaglutide and blood clots is far more complicated than a single relative risk number suggests
Feb 5, 2026 Day one, you step on the scale and write down the number
After this period, your provider may recommend: A 1-2 month break before resuming Continued treatment with periodic monitoring Dose adjustments based on your response Long-term use beyond 6 months should include periodic lab testing (IGF-1 levels, metabolic panel) and provider evaluation
Two ways to get started: Two ways to get started: Option 1: Start with Bloodwork Establish your baseline with our comprehensive 100+ biomarker panel, then access treatments that target your specific optimization opportunities
The core semaglutide patent does not expire until 2032, with additional protections lasting even longer for specific delivery mechanisms and dosage forms
